Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r

Details Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r

1997-01-22

1998-08-04

Grumbling, Matthew V.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514256, 514318, 514322, 514393, 544295, 544333, 544364, 546194, 546210, 5483021, A61K 31495, A61K 31505, C07D40102, C07D40302

Patent

active

057894108

ABSTRACT:
Disclosed are compounds encompassed by the following general formula: ##STR1## wherein, A represents ethenylene, or A represents --X--CH.sub.2 --; where X is carbon or oxygen, provided that when X is oxygen, the oxygen is adjacent the 6-membered ring;

REFERENCES:
patent: 4461894 (1984-07-01), Omodei-Sale
patent: 5214040 (1993-05-01), Cuberes-Altisent
patent: 5409931 (1995-04-01), Caprathe et al.
patent: 5418237 (1995-05-01), Bottcher et al.
patent: 5444059 (1995-08-01), Frigola-Constansa
patent: 5447931 (1995-09-01), Baroni et al.

Affiliated with

Also associated with

Rating

Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine r will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1177424